Janney Montgomery Scott
OREX

Janney Montgomery Scott’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Janney Montgomery Scott’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,220
Closed -$18K – 1566
2016
Q2 		$18K Buy
4,220
+1,235
+41% +$5.58K ﹤0.01% 622
2016
Q1 		$17K Buy
2,985
+38
+1% +$493 ﹤0.01% 1256
2015
Q4 		$51K Buy
2,947
+202
+7% +$4.82K ﹤0.01% 1334
2015
Q3 		$58K Buy
2,745
+300
+12% +$10.3K ﹤0.01% 1359
2015
Q2 		$121K Buy
2,445
+812
+50% +$48.5K ﹤0.01% 1934
2015
Q1 		$128K Buy
+1,633
New +$101K ﹤0.01% 2244

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Janney Montgomery Scott's OREX Position: Q3 2016 in Review

Janney Montgomery Scott sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2016, closing a stake of 4,220 shares — an estimated $18K sold.

Janney Montgomery Scott first reported a position in OREX in Q1 2015 and held it in 6 quarters. The position peaked at $128K in Q1 2015. 55 funds tracked by Wall St. Rank hold OREX as of Q3 2016.

  • Janney Montgomery Scott reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Janney Montgomery Scott sold 4,220 Orexigen Therapeutics, Inc. shares in Q3 2016, an estimated $18K.
  • Janney Montgomery Scott first reported a position in Orexigen Therapeutics, Inc. in Q1 2015 and held it in 6 quarters.
  • Janney Montgomery Scott's Orexigen Therapeutics, Inc. position peaked at $128K in Q1 2015.
  • 55 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2016.

Based on Janney Montgomery Scott's 13F filing for Q3 2016, filed 14 Nov 2016.